Ceapro Stock Price

TSXV:CZOCA$17.6mMaterials

CZO Share Price Performance

CZO Community Fair Values

View all narratives

Recent CZO News & Updates

No updates

Ceapro Inc. Competitors

About CZO

Founded: 1997
Employees: n/a
CEO: Gilles Gagnon
WebsiteView website: www.ceapro.com

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also offers natural active ingredients, including oat powder, oat oil, oat peptides, and lupin peptides to the personal care, cosmetic, medical, and animal health industries; anti-aging skincare products to the cosmeceutical industries; and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. The company has a research collaboration with the Angiogenesis Foundation. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Ceapro Inc. Key Details

Last Reported Earnings

Dec 31, 2023

Yearly revenue growth

n/a

Earnings per share (EPS): -0.06
Gross Margin: 41.07%
Net Profit Margin: -48.89%
Debt/Equity Ratio: 0%

View full report ›

Canadian Market Performance

7 Days: 1.4%
3 Months: 18.1%
1 Year: 19.9%
Year to Date: 8.8%

Over the last 7 days, the market has risen 1.4%, driven by gains of 3.4% in the Materials sector. As for the past 12 months, the market is up 20%. Earnings are forecast to grow by 12% annually. Market details ›